Jan 5, 2024
January 26, 2025
This week’s newsletter included:
- Participate in Life Sciences Day on Capitol Hill
- Utah Track from the 2023 Utah Life Sciences Summit
- Headed to J.P. Morgan
- Co-Diagnostics Completes Submission to FDA for Co-Dx PCR Pro
- PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation
- Canyon Labs: Senior Leadership Changes
- BlueWind Medical Brings Revi Implantable Tibial Neuromodulation Device to Patients
- Bench to Bedside Mentor Mixer & CMI Open-House
- Utah Ranked as the Best State for Economic Mobility
- Utah Ranks #5 in 2023 Best States for Manufacturing
- Utah Business: Is Silicon Valley Bank Back? Here’s How the Bank Is Rebuilding in Utah
- IMA Issues Life Sciences Industry Report
- Nasdaq Spotlights Myriad Genetics’ New CFO, Scott Leffler
- Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Featured New Member: Eris Biotech
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
